Cargando…
NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis
BACKGROUND: Activation of the NLRP3 inflammasome in gout amplifies the inflammatory response and mediates further damage. In the current study, we assessed the therapeutic effect of OLT1177, an orally active NLRP3 inflammasome inhibitor that is safe in humans, in murine acute arthritis models. METHO...
Autores principales: | Marchetti, Carlo, Swartzwelter, Benjamin, Koenders, Marije I., Azam, Tania, Tengesdal, Isak W., Powers, Nick, de Graaf, Dennis M., Dinarello, Charles A., Joosten, Leo A. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091035/ https://www.ncbi.nlm.nih.gov/pubmed/30075804 http://dx.doi.org/10.1186/s13075-018-1664-2 |
Ejemplares similares
-
Dexamethasone and OLT1177 Cooperate in the Reduction of Melanoma Growth by Inhibiting STAT3 Functions
por: Dinarello, Alberto, et al.
Publicado: (2023) -
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
por: Marchetti, Carlo, et al.
Publicado: (2018) -
The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer’s disease
por: Lonnemann, Niklas, et al.
Publicado: (2020) -
OLT1177 (Dapansutrile), a Selective NLRP3 Inflammasome Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis
por: Sánchez-Fernández, Alba, et al.
Publicado: (2019) -
Activation of Host-NLRP3 Inflammasome in Myeloid Cells Dictates Response to Anti-PD-1 Therapy in Metastatic Breast Cancers
por: Tengesdal, Isak W., et al.
Publicado: (2022)